Health Catalyst Inc
Health Catalyst Inc (HCAT) is a healthcare data and analytics company that builds cloud-based platforms to help providers measure and improve clinical and financial outcomes. Its software combines data warehousing, analytics, and machine learning to support population health, care management and operational performance across hospitals and health systems. With a market capitalisation near $224m, HCAT is a relatively small, growth-oriented company that can be more volatile than larger peers. Revenue depends on adoption by health systems, recurring subscription contracts, and professional services. Investors should note competitive pressure from larger healthcare IT vendors, the pace of hospital digital transformation, and reimbursement or regulatory changes that affect customers’ budgets. This summary is educational, not personalised advice — values can rise and fall and returns are not guaranteed. Always check recent financials, management commentary and suitability for your objectives before considering any investment.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Health Catalyst's stock with a target price of $10.54, indicating growth potential.
Financial Health
Health Catalyst is performing well with strong revenue and cash flow, indicating good financial stability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring HCAT
Enterprise Software Buyout Boom
Private equity firm Thoma Bravo is acquiring HCM software leader Dayforce for $12.3 billion, taking the company private. This major deal highlights a trend of consolidation in the enterprise software sector, creating potential opportunities for other publicly-traded HCM and AI-focused software companies.
Published: August 23, 2025
Explore BasketHealthcare's Cybersecurity Imperative
The massive cyberattack on UnitedHealth's subsidiary has exposed critical vulnerabilities within the national healthcare system. This event is accelerating the demand for advanced cybersecurity solutions, creating a significant growth opportunity for firms that specialize in protecting sensitive medical data and infrastructure.
Published: August 15, 2025
Explore BasketHealthcare's Efficiency Imperative
UnitedHealth Group's recent profit miss, driven by high medical costs, has triggered a major cost-cutting initiative across the company. This move signals a broader industry trend, creating an investment opportunity in companies that provide AI and technology solutions to help healthcare organizations improve efficiency and reduce operational expenses.
Published: July 30, 2025
Explore BasketRiding The Regulatory Wave In Healthcare
The Department of Justice's investigation into UnitedHealth's Medicare billing practices has cast a shadow over the health insurance industry, potentially leading to stricter oversight. This creates an investment opportunity in companies that provide compliance and auditing services, which are essential for navigating a more complex regulatory environment.
Published: July 25, 2025
Explore BasketHealthcare Billing Integrity
This group of stocks includes companies positioned to benefit from increased focus on healthcare billing compliance. Carefully selected by professional analysts, these stocks represent both healthcare tech providers offering compliance solutions and competing insurers who may gain market share amid regulatory scrutiny.
Published: July 11, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Data-driven healthcare
Platform analytics and machine learning can help hospitals improve outcomes and efficiency, though adoption cycles and competition can affect growth.
Health system focus
Customers are predominantly hospitals and health systems, so sector spending and regulation influence demand; performance can vary with policy changes.
Small-cap dynamics
With a modest market capitalisation, HCAT can offer growth potential but also greater share-price volatility and liquidity risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
